Nurse at centre of gender storm takes action against union
Sandie Peggie was suspended from her job in 2024 after she complained about having to share a changing room with transgender medic Dr Beth Upton.
Ms Peggie was later placed on special leave after a complaint of bullying and harassment by Dr Upton, but was cleared by an NHS Fife investigation earlier this week.
The suspension led to an employment tribunal this year, in which Ms Peggie launched a claim against Dr Upton and NHS Fife, citing the Equality Act 2010, including sexual harassment, harassment related to a protected belief, indirect discrimination and victimisation.
On Saturday, the Herald reported that Ms Peggie had taken legal action against the Royal College of Nursing (RCN), claiming it failed to support her after her suspension, which the union denies.
'The RCN's failure to act like a trade union ought to has contributed to Sandie Peggie's mistreatment,' Ms Peggie's lawyer Margaret Gribbon said in a statement.
'They have repeatedly failed to exercise their industrial muscle to advocate for female members distressed because they are being deprived of genuine single-sex spaces to dress and undress at work.
'Had the RCN fulfilled the conventional role of a trade union, it is less likely that Sandie would have faced the ordeal of an 18-month disciplinary process and having to raise legal proceedings against Fife Health Board.'
The paper reported that Ms Peggie will be taking action for unlawful discrimination.
An RCN spokesperson told the newspaper: 'We have responded to the claim, and we deny all the allegations from Ms Peggie.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
23 minutes ago
- Yahoo
Akari Therapeutics Participates in the Virtual Investor 'What's Your Story' Summer Spotlight On-Demand Conference
Video webcast now available on-demand BOSTON and LONDON, July 22, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel immuno-oncology payload antibody drug conjugates (ADCs) for the treatment of cancer, today announced Abizer Gaslightwala, Director, President and Chief Executive Officer of Akari, participated in the Virtual Investor 'What's Your Story' Summer Spotlight On-Demand Conference. As part of the event, Mr. Gaslightwala dove deeper into his dedication to the Company, how he got to where he is today and provided insight into why he is so passionate about the Company's programs in development. The on-demand video webcast is now available on as well as the Presentations page in the Investors section of the Company's website ( About Akari Therapeutics Akari Therapeutics is an oncology biotechnology company developing novel payload antibody drug conjugates (ADCs). The Company has developed its first novel payload, PH1, a spliceosome inhibitor designed to disrupt RNA splicing within cells. PH1 is highly differentiated in its mechanism of action against cancer cells from current ADC payloads that use Topoisomerase1 inhibitors or tubulin inhibitors. This splicing inhibition has been shown in preclinical animal models to induce cancer cell death while activating immune cells to drive robust and durable activity. Using this novel payload, Akari has the ability to generate multiple ADC molecules based on the desired application to a range of cancer targets of interest. Akari's lead candidate, AKTX-101, targets the Trop2 receptor on cancer cells and delivers its novel PH1 payload directly into the tumor. In preclinical studies, AKTX-101 has shown to have significant activity and prolonged survival, relative to ADCs with traditional payloads. Additionally, AKTX-101 has the potential to be synergistic with checkpoint inhibitors and has demonstrated prolonged survival as both a single agent and in combination with checkpoint inhibitors, as compared to appropriate controls. The Company is generating validating data on its novel payload PH1 to continue advancing its lead asset, as well as other undisclosed targets with this novel payload. For more information about the Company, please visit and connect on X and LinkedIn. Investor Relations Contact JTC Team, LLC Jenene Thomas 908-824-0775 AKTX@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Forbes
26 minutes ago
- Forbes
Can A Chatbot Be Your Therapist? Casper's Neil Parikh Launches A New $93 Million Startup To Try
Daniel Cahn (left) and Neil Parikh (right), cofounders of Slingshot AI. courtesy of slingshot N eil Parikh's first startup Casper made sleep easy—and even cool. The med school dropout used tech to help people buy mattresses with just a few clicks. Now he wants to make getting therapy just as simple. After turning the sleep brand into a billion-dollar business, the Forbes Under 30 alum is back with a new venture: Slingshot AI, a startup building a chatbot designed to replicate the experience of talking to a therapist. 'I never really thought about therapy,' Parikh told Forbes . 'Then I found a therapist who changed my life.' That's how it clicked for the entrepreneur. While millions struggle with mental health issues, access to care is staggeringly limited. 'We realized there's over 10,000 people who want care for every therapist that's out there,' he said. 'There was an opportunity for AI to actually help people in a new way.' On Tuesday, Slingshot officially launched its AI-powered therapy bot, called Ash, and announced a follow-on Series A round co-led by Radical Ventures and Forerunner Ventures, with participation from existing investors Andreessen Horowitz, Menlo Ventures and others. The round brings Slingshot's total funding to $93 million as it emerges from beta after being tested with more than 50,000 users. Parikh founded the startup with Daniel Cahn, a machine learning engineer who previously worked on AI tools for mental health in the UK. Unlike general purpose models like ChatGPT—which pull data from the internet—Ash was developed in collaboration with clinicians and trained specifically on behavioral health data. It doesn't offer advice or try to diagnose, but is instead designed to guide users more through self-reflection, similar to how a therapist might prompt deeper thinking. Andreessen Horowitz's a16z was quick to back the entrepreneur. Daisy Wolf, partner at the firm, said they'd been actively looking for a startup bringing AI into the mental health space, handing Slingshot a term sheet as soon as the team was ready to raise. 'They have the experience and know how to pull this off. They've been absolute magnets for talent, and the caliber of people they've been able to recruit has continued to blow us away,' Wolf said. Parikh was 22 when he dropped out of medical school to build Casper. The company wasn't the first to sell mattresses online, but it was the first to become a household name with mattress-in-a-box convenience and a wellness-focused message that turned sleep into a lifestyle. Celebrity endorsements and subway ads helped build the brand amongst a younger audience. Parikh went all in and even co-authored a book on sleep. Casper went public in 2020 at $12 a share—below its target range—and returned to private ownership two years later. He stepped down in 2021 and fully exited the board after the sale. Since then, he's invested in more than 150 startups, many tied to mental health. Now back in the founder seat, he says building from the ground up is both daunting and exciting. 'Every part of this business is really challenging when you think about it. You have to build a large scale data set through partnerships. You have to build a team that knows how to train AI models. You actually have to learn how to train the models,' he said. The burning question: Can a chatbot really compare to a human therapist? Though the concept of AI therapy might seem experimental, early evidence suggests it could have real potential. At Dartmouth College, researchers developed and tested their own chatbot therapist called Therabot. In a trial of more than 100 people with mental health conditions, all improved. Those with depression saw a 51% symptom drop on average. Nicholas Jacobson, one of the clinicians behind Therabot, said chatbots can offer several advantages over traditional care, including cost, convenience and 24/7 availability. Even individuals who had not previously responded to therapy saw significant improvement with Therabot. "A full caseload is about 26-and-a-half patients a week for a practicing therapist,' he said. 'They will see their patients generally once a week in outpatient settings for about 45 minutes.' In that case, why not use the widely popular generative AI models like ChatGPT or Google's Gemini? While these models are incredibly advanced, they aren't designed specifically for mental health care, Jacobson said, and can be potentially harmful. At Dartmouth, this meant researchers had to build their own data from scratch. At Slingshot, it means partnering directly with clinicians—and using that $93 million to build a better data pipeline. And, Parikh adds, general models can be somewhat of yes-men. 'You want them to appropriately push back on you. That's a core part of self growth.' Courtesy of Slingshot Still, not everyone is convinced chatbots can handle mental health responsibly. Critics have raised concerns about safety and privacy. Slingshot says it's proactively addressing these issues by working with a clinical advisory board. Ash, for example, redirects users experiencing a serious crisis to human professionals. This time around, the serial entrepreneur (who's gone to plenty of therapy since) wants to keep the company lean and mission-driven. For its initial launch, Ash will be available for free to users, and Parikh imagines rolling out a subscription model priced similarly to Netflix. In the future, there may be avenues for Ash to be available via employers or insurance. In the meantime, Parikh says he isn't trying to reinvent therapy, but hoping Ash might just help more people start it. 'Doing anything that nobody's done before means that you have to figure out a lot of new things,' he said. 'It's a lot of unknown nodes, but it's also cool because every day we get to wake up and get feedback from people who say this is incredible and their lives changed.'
Yahoo
an hour ago
- Yahoo
Row over NHS doctor strike deepens as poll suggests public support is waning
The row between the British Medical Association (BMA) and health leaders over the upcoming doctor strike has deepened as research suggests public support for the action is waning. NHS Providers, which represents hospital trusts, hit back at BMA claims that health leaders were putting patients at risk, saying it was actually the 'costly' BMA strike that was risking patient care. It comes as Health Secretary Wes Streeting told the House of Commons he 'sincerely hopes the BMA will postpone' the 'unnecessary and irresponsible' strikes to continue talks with the Government, which he said had been 'constructive' in recent days. He said, however, the Government stands 'ready' and 'responsive' if the five-day strike by resident doctors, which is scheduled to start at 7am on Friday, does go ahead. Earlier, the BMA said NHS England plans for managing the strike could put patients at risk owing to the fact it has ordered hospitals to continue with as much pre-planned care as possible. We've written to NHS England with concerns about inadequate planning ahead of possible strike action later this week. Attempts to run non-urgent services with fewer doctors risk patient safety. It's imperative that Trusts postpone work to protect urgent and emergency care. — The BMA (@TheBMA) July 21, 2025 Previous strikes by health workers have seen hundreds of thousands of operations and appointments cancelled, but NHS England is taking a different approach this time to managing the strike. In a letter to hospital trust leaders, it urges the health system to focus on maintaining emergency care, maintaining the flow of patients and 'maintaining elective care to the fullest extent possible' as well as 'priority treatments' such as cancer care. 'It will be important for systems and trusts to try and maintain normal levels of booked activity…' it said, adding: 'Reducing volumes of bookings and rescheduling of appointments and other activity should only happen in exceptional circumstances to safeguard patient safety.' On Tuesday morning, BMA deputy chairwoman Dr Emma Runswick told BBC Radio 4's Today programme this plan risked patient safety. She said: 'We've had proven systems over the last decade that have made sure that where we have to take strike action, senior doctors cover urgency and critical care. 'This time round, NHS England are pushing for the continuation of non-urgent and scheduled care in a way that we think at best is confusing and will create on-the-day cancellations – and at worst could be risky and lead to harm in emergency departments and on wards, because senior doctors cannot physically be in two places at once. 'We think that a notional guidance from NHS England which is saying that basically all scheduled work should continue to go ahead has potential to be seriously risky for patients… 'Senior doctors are needed to be freed up in order to provide urgency and critical care. 'We think the vast majority of planned and unscheduled care should be shifted.' NHS Providers hit back at the BMA's claims, saying it was the strike itself that posed a risk to patients. Its chief executive, Daniel Elkeles, said: 'The NHS, not the BMA, is putting patients' interests first. 'Given that some patients will be caused undoubted harm if the short-notice strike goes ahead, NHS trusts are doing the responsible thing by not cancelling people's care while talks to avert the strike are ongoing. 'Now is a time for cool heads in the BMA because it's not too late to avoid a damaging, costly strike. NHS trust leaders hope for a breakthrough from talks between Government and the union. 'If the strike goes ahead then NHS trusts will do everything they can to avoid any harm to patients and are planning for as many patients as possible to be cared for.' It comes as a new YouGov poll showed about half (52%) of people in the UK either 'somewhat oppose' (20%) or 'strongly oppose' (32%) the idea of resident doctors going on strike over pay. Meanwhile, a third (34%) of the 4,954 adults surveyed either 'somewhat support' (23%) or 'strongly support' (11%) doctor strikes. YouGov said the proportion supporting the strike over pay has dropped five points since it last asked the question in May. Then, 48% opposed resident doctors striking, while 39% supported them taking action. Speaking in the Commons on Tuesday, Mr Streeting said that before he came into office, 'strikes were crippling the NHS'. He added: 'Costs ran to £1.7 billion in just one year, and patients saw 1.5 million appointments rescheduled. 'Strikes this week are not inevitable, and I sincerely hope the BMA will postpone this action to continue the constructive talks my team and I have had with them in recent days. 'Regardless, our priority is to keep patients safe, and we will do everything we can to mitigate the impacts of strikes on patients and the disruption that will follow should these totally unnecessary and avoidable strikes go ahead.' Quizzed by MPs, he said the 'approach we're taking is different from that taken in previous periods of strike action'. He added: 'NHS leaders have been clear to me that previous rounds of strike action caused much wider levels of harm than previously realised, and there is no reason why planned care in issues like cancer, for example, cancer appointments, as well as other conditions should be treated as somehow less important or second fiddle to other NHS services. 'That is why the chief executive of NHS England has written to NHS leaders asking them to keep routine operations going to the fullest extent possible, as well as continuing priority treatments. 'It will be for local leaders to determine what's possible given staffing levels. 'That's why it's really important that resident doctors do engage with their employers about their determination or not to turn up at work this week, and why again, I just spell out the serious consequences for patients that means that these avoidable and unnecessary strikes should not go ahead.' Consultants and SAS doctors in England – look out for your indicative ballot email from @TheBMA today! Wes Streeting called pay restoration "a journey, not an event" – so why have we stopped? Are you prepared to stand up to demand your value is recognised by the government? — Tom Dolphin🏳️🌈 🏳️⚧️ (@thomasdolphin) July 21, 2025 Elsewhere, the BMA has also issued strike guidance for consultants regarding the extra pay they can seek for covering work that is not in their contracts. The BMA 'rate card' says consultants can ask for £188 per hour on weekdays from 7am-7pm and £250 an hour from 7pm to 11pm. At weekends, the pay claim can rise to £250 per hour from 7am to 11am and £313 per hour for overnight work from 11pm to 7am. Resident doctors, formerly known as junior doctors, were awarded an average 5.4% pay increase this financial year, following a 22% rise over the previous two years. However, the BMA says real-terms pay has still fallen by around 20% since 2008, and is pushing for full 'pay restoration'. Resident doctors are qualified doctors in clinical training. They have completed a medical degree and can have up to nine years of working experience as a hospital doctor, depending on their specialty, or up to five years of working and gaining experience to become a GP.
